65277-91-0
65277-91-0
Chemical Structure
DPPC-13C2
Synonym(s): 129Y83-13C2
- CAS No.: 65277-91-0
- Formula:C3813C2H80NO8P
- Molecular Weight:736.02
IUPAC Name: N-(6-chloro-2'-fluoro-[1,1'-biphenyl]-3-yl)-4-(2-chloroacetyl)piperazine-1-carboxamide
InChIKey: KILNVBDSWZSGLL-NYGHEXGZSA-N
SMILES: CCCCCCCCCCCCCCC[13C](O[C@H](CO[13C](CCCCCCCCCCCCCCC)=O)COP(OCC[N+](C)(C)C)([O-])=O)=O
Biological Activity: DPPC-13C2 is a deuterated labeled DPPC[1]. DPPC (129Y83) is a phosphoglyceride that can be used to prepare lipid monolayers, bilayers, and liposomes. DPPC is the main lipid component of pulmonary surfactant. Dppc-liposome can be effectively used as a delivery vector to induce an immune response against GSL antigen in mice[2][3][4][5][6].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
DPPC-13C2 | 95.0% | DPPC-13C2 is a deuterated labeled DPPC. DPPC (129Y83) is a phosphoglyceride that can be used to prepare lipid monolayers, bilayers, and liposomes. DPPC is the main lipid component of pulmonary surfactant. Dppc-liposome can be effectively used as a delivery vector to induce an immune response against GSL antigen in mice. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DPPC (Standard) | 99.95% | DPPC (Standard) is the analytical standard of DPPC. This product is intended for research and analytical applications. DPPC (129Y83) is a phosphoglyceride that can be used to prepare lipid monolayers, bilayers, and liposomes. DPPC is the main lipid component of pulmonary surfactant. Dppc-liposome can be effectively used as a delivery vector to induce an immune response against GSL antigen in mice. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DPPC-d66 | DPPC-d66 is deuterium labeled DPPC. DPPC (129Y83) is a zwitterionic phosphoglyceride that can be used for the preparation of liposomal monolayers. DPPC-liposome serves effectively as a delivery vehicle for inducing immune responses against GSL antigen in | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DPPC-d75 | DPPC-d75 is deuterium labeled DPPC. DPPC (129Y83) is a zwitterionic phosphoglyceride that can be used for the preparation of liposomal monolayers. DPPC-liposome serves effectively as a delivery vehicle for inducing immune responses against GSL antigen in | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DPPC-d31 | 16:0-16:0 PC-d31 is deuterium labeled 16:0-16:0 PC. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DPPC-d71 | 99.0% | DPPC-d71 is deuterium labeled DPPC. DPPC (129Y83) is a zwitterionic phosphoglyceride that can be used for the preparation of liposomal monolayers. DPPC-liposome serves effectively as a delivery vehicle for inducing immune responses against GSL antigen in | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DPPC-13C | DPPC-13C3 (129Y83-13C) is the 13C-labeled DPPC (HY-109506). DPPC (129Y83) is a phosphoglyceride that can be used to prepare lipid monolayers, bilayers, and liposomes. DPPC is the main lipid component of pulmonary surfactant. Dppc-liposome can be effectively used as a delivery vector to induce an immune response against GSL antigen in mice. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DPPC-d31 | 1-Palmitoyl-2-palmitoyl-sn-glycero-3-phosphocholine-d31 is deuterium labeled 1-Palmitoyl-2-palmitoyl-sn-glycero-3-phosphocholine. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DPPC-d9-1 | DPPC-d9-1 is the deuterium labeled DPPC. DPPC (129Y83) is a zwitterionic phosphoglyceride that can be used for the preparation of liposomal monolayers. DPPC-liposome serves effectively as a delivery vehicle for inducing immune responses against GSL antigen in mice. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DPPC-d13 | DPPC-d13 is deuterium labeled DPPC. DPPC (129Y83) is a zwitterionic phosphoglyceride that can be used for the preparation of liposomal monolayers. DPPC-liposome serves effectively as a delivery vehicle for inducing immune responses against GSL antigen in | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(Rac)-DPPC-d6 | (Rac)-DPPC-d6 is a deuterated labeled DPPC. DPPC (129Y83) is a phosphoglyceride that can be used to prepare lipid monolayers, bilayers, and liposomes. DPPC is the main lipid component of pulmonary surfactant. Dppc-liposome can be effectively used as a delivery vector to induce an immune response against GSL antigen in mice. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DPPC-d4 | 99% | DPPC-d4 is deuterium labeled DPPC. DPPC (129Y83) is a zwitterionic phosphoglyceride that can be used for the preparation of liposomal monolayers. DPPC-liposome serves effectively as a delivery vehicle for inducing immune responses against GSL antigen in m | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DPPC-d9 | 95.0% | DPPC-d9 is the deuterium labeled DPPC. DPPC (129Y83) is a zwitterionic phosphoglyceride that can be used for the preparation of liposomal monolayers. DPPC-liposome serves effectively as a delivery vehicle for inducing immune responses against GSL antigen in mice. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DPPC-d62 | 99% | DPPC-d62 is the deuterium labeled DPPC. DPPC (129Y83) is a zwitterionic phosphoglyceride that can be used for the preparation of liposomal monolayers. DPPC-liposome serves effectively as a delivery vehicle for inducing immune responses against GSL antigen in mice. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DPPC | 99.91% | DPPC (129Y83) is a phosphoglyceride that can be used to prepare lipid monolayers, bilayers, and liposomes. DPPC is the main lipid component of pulmonary surfactant. Dppc-liposome can be effectively used as a delivery vector to induce an immune response against GSL antigen in mice. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]
- [2]. Miller AD. Delivery of RNAi therapeutics: work in progress. Expert Rev Med Devices. 2013 Nov;10(6):781-811. [Content Brief]
- [3]. Akiko Uemura, et al. Induction of immune responses against glycosphingolipid antigens: comparison of antibody responses in mice immunized with antigen associated with liposomes prepared from various phospholipids. J Vet Med Sci. 2005 Dec;67(12):1197-201. [Content Brief]
- [4]. Ege C, et al. Insertion of Alzheimer's A beta 40 peptide into lipid monolayers. Biophys J. 2004 Sep;87(3):1732-40. [Content Brief]
- [5]. Kalra VK, et al. Transport of amino acids in gamma-glutamyl transpeptidase-implanted human erythrocytes. J Biol Chem. 1981 Jun 10;256(11):5567-71. [Content Brief]
- [6]. Leekumjorn S, et al. Molecular simulation study of structural and dynamic properties of mixed DPPC/DPPE bilayers. Biophys J. 2006 Jun 1;90(11):3951-65. [Content Brief]
